US 11160826
Cholesterol lowering drugs for the treatment of hepatic encephalopathy
granted A61KA61K31/724A61P
Quick answer
US patent 11160826 (Cholesterol lowering drugs for the treatment of hepatic encephalopathy) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/724, A61P, A61P1/16, A61P25/28